Liquid Biopsy Market Role in Personalized and Targeted Cancer Treatment 2031
The Liquid Biopsy Market is gaining importance in treatment monitoring. Repeated blood-based testing can potentially provide information about changes in tumor biology without requiring repeated invasive tissue procedures. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering an estimated CAGR of 11.2% through 2031....
0 Commentarios 0 Acciones 9 Views 0 Vista previa